Open Label, Phase I ZD6474 Head and Neck Cancer Study

• Status: Completed
• Trial end date: 2011-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the maximum tolerated dose of ZD6474 given in combination with radiation or in combination with chemotherapy and radiation in patients with squamous cell carcinoma of the head and neck.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sanofi
• Treatments: Cisplatin

Criteria

Inclusion Criteria:

• Stage III-IV squamous cell carcinoma of the head and neck

Exclusion Criteria:

• No previous treatment for head and neck cancer, adequate cardiac function